Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle

BACKGROUND: Pharmaceutical interventions for diabetes aim to control glycaemia and to prevent the development of complications, such as cardiovascular diseases. Some anti-hyperglycaemic drugs have been found to have adverse cardiovascular effects in their own right, limiting their therapeutic role....

Descripción completa

Detalles Bibliográficos
Autores principales: Al-aryahi, Sefaa, Kamato, Danielle, Getachew, Robel, Zheng, Wenhua, Potocnik, Simon J, Cohen, Neale, Guidone, Daniel, Osman, Narin, Little, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016772/
https://www.ncbi.nlm.nih.gov/pubmed/24731772
http://dx.doi.org/10.1186/1475-2840-13-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016772/
https://www.ncbi.nlm.nih.gov/pubmed/24731772
http://dx.doi.org/10.1186/1475-2840-13-80

Ejemplares similares